Psychosis Mental and Behavioural Disorders
Conditions
Interventions
After baseline assessments, clinicians will be randomized to the intervention (DIALOG+ for 12 months) or control (TAU for 12 months), with an allocation ratio of 1:1.
The intervention group will rec
Sponsors
European Commission, Directorate-General for Research and Innovation
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Clinicians: 1. Having a professional qualification in mental health care 2. More than 6 months’ experience of working in mental health care 3. No plans to leave their post within the study period Patients: 1. Primary diagnosis of psychosis or related disorder (i.e.: ICD-10 F20-29, F31) 2. Aged 18 years or older 3. Attending the outpatient clinic or day hospital 4. History of at least one hospital admission in their lifetime 5. There should not be plans to be discharged from mental health care services for the next 12 months 6. Capacity to provide informed consent
Exclusion criteria
Exclusion criteria: Clinicians: 1. No exclusion criteria Patients: 1. Having a diagnosis of organic brain disorders 2. Having severe cognitive deficits (unable to provide information to study instruments). This will be based on the clinical judgement
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline, 6 months and 12 months: 1. Treatment satisfaction measured using Client Satisfaction Questionnaire (CSQ)-8 2. Clinical symptoms measured using Brief Symptom Inventory (BSI), Brief Psychiatric Rating Scale (BPRS), and Clinical Assessment Interview for Negative Symptoms (CAINS) | — |
Primary
| Measure | Time frame |
|---|---|
| Subjective quality of life measured by Manchester Short Assessment of Quality of Life (MANSA) at baseline, 6 months and 12 months | — |
Countries
Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia, Serbia
Contacts
Public ContactTamara Pemovska
Outcome results
None listed